SCHEMBL1649648

SCHEMBL1649648

[99Tc]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29494657 1.00
SCHEMBL9175196 1.00
SCHEMBL29375646 1.00
SCHEMBL25902 1.00
SCHEMBL11034701 1.00
SCHEMBL27620250 1.00
SCHEMBL28319254 1.00
SCHEMBL29872243 1.00
Iodide SCHEMBL10729245 0.71 CA4 (0.33)
Hydrochloric Acid SCHEMBL11141820 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3418 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122094718-A Image-guided biopsy of HER2 positive lesions 2026-05-26 CN claimed
US-20260137821-A1 PEPTIDE STRUCTURE TARGETING CARBONIC DEHYDROGENASE IX AND USE THEREOF C-BIOMEX CO., LTD. (KR) 2026-05-21 US claimed
EP-4743489-A1 HUMANISED ANTIBODIES AND USES THEREOF Telix Pharmaceuticals (Innovations) Pty Ltd (AU) 2026-05-20 EP claimed
WO-2026099761-A1 PEPTIDES SALEM YAHYA AHMED (EG) 2026-05-15 WO claimed
WO-2026098441-A1 COMPOSITION AND METHOD FOR CANCER TREATMENT USING POLYPEPTIDE CONJUGATES SUZHOU SMARTNUCLIDE BIOPHARMACEUTICAL CO., LTD. (CN) 2026-05-15 WO claimed
EP-4736841-A1 A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT IQ medical GmbH (DE) 2026-05-06 EP claimed
EP-4735045-A2 OXAZAPHOSPHORINE ANTIBODY DRUG CONJUGATES AND METHODS OF USE La Life Products, LLC (US) 2026-05-06 EP claimed
US-20260115332-A1 Fibroblast Activation Protein Alpha-Cleavable Pro-Peptides and Methods of Use UNIV CALIFORNIA (US) 2026-04-30 US claimed
EP-4476181-B1 METHOD FOR PURIFYING RUTHENIUM FROM TECHNETIUM AND METAL IMPURITIES IN AQUEOUS NITRIC ACID SOLUTION COMMISSARIAT ENERGIE ATOMIQUE (FR) 2026-04-01 EP claimed
EP-4716551-A2 PROTEINS THAT BIND SP17 INCLUDING FULLY-HUMAN ANTI-SP17 ANTIBODIES Medicovestor, Inc. (US) 2026-04-01 EP claimed
WO-2022061168-A1 E-SELECTIN TARGETING AGENTS GLYCOMIMETICS, INC. (US) 2022-03-24 WO claimed
EP-3247727-B1 INHIBITORS OF THE INTERACTION BETWEEN CLEC14A AND MULTIMERIN-2 FOR INHIBITION OF ANGIOGENESIS CANCER RESEARCH TECH LTD (GB) 2022-03-23 EP claimed
CN-114206796-A Radiopaque glass material ABK生物医学公司 2022-03-18 CN claimed
WO-2022053651-A2 ANTIBODY FRAGMENT AGAINST FAP PRECIRIX N.V. (BE) 2022-03-17 WO claimed
EP-3968342-A1 APPARATUS FOR PRODUCING RADIONUCLIDE AND METHOD FOR PRODUCING RADIONUCLIDE Hitachi, Ltd. (JP) 2022-03-16 EP claimed
CN-114163478-A Technetium-99 m labeled D-proline modified FAPI derivative and preparation method and application thereof 北京师范大学 2022-03-11 CN claimed
US-20220044836-A1 TECHNETIUM 99M ISOLATION SYSTEM AND TECHNETIUM 99M ISOLATION METHOD KYOTO MEDICAL TECHNOLOGY CO., LTD (JP) 2022-02-10 US claimed
CN-113970778-A Method for rapidly analyzing technetium-99 content in water sample 中国辐射防护研究院 2022-01-25 CN claimed
US-11229710-B2 Environmentally sensitive compositions comprising a pH-triggered membrane protein and methods of use thereof in the treatment and diagnosis of tumors UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) 2022-01-25 US claimed
EP-0441953-A1 NEW CORES FOR TECHNETIUM RADIOPHARMACEUTICALS. AMERSHAM INT PLC (GB) 1991-08-21 EP claimed